Cemiplimab Studied as Neoadjuvant Therapy for Cutaneous SCC

MONDAY, Sept. 12, 2022 (HealthDay News) -- Fifty-one percent of patients...

New MS Discovery Could Lead to Treatments That Prevent Disease Progression, Study Finds

Study Takes Long-Term Look at Benefits of Radiation After Breast Lumpectomy

FRIDAY, Nov. 18, 2022 (HealthDay News) -- If you're diagnosed with early breast...

Nearly 10 Percent of Younger Children Have Gotten First COVID-19 Vaccine Dose

THURSDAY, Nov. 18, 2021 (HealthDay News) -- Almost one in 10 eligible U.S....